lapatinib has been researched along with piroxicam in 4 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (piroxicam) | Trials (piroxicam) | Recent Studies (post-2010) (piroxicam) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 3,084 | 796 | 704 |
Protein | Taxonomy | lapatinib (IC50) | piroxicam (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.3043 | |
Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.1 | |
Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Iio, A; Kaji, K; Maeda, S; Momoi, Y; Motegi, T; Nakazawa, M; Sakai, K; Yonezawa, T | 1 |
1 review(s) available for lapatinib and piroxicam
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lapatinib and piroxicam
Article | Year |
---|---|
Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gene Expression Regulation, Neoplastic; Lapatinib; Male; Muscles; Piroxicam; Protein Kinase Inhibitors; Receptor, ErbB-2; Treatment Outcome; Urinary Bladder Neoplasms | 2022 |
2 other study(ies) available for lapatinib and piroxicam
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |